NM Board of Pharmacy mailing address:
5500 San Antonio Dr. NE Suite C
Albuquerque NM 87109
Monday through Friday 8:00AM through 5:00PM MST
The New Mexico Board of Pharmacy regulates the pharmaceutical industry that includes licensing pharmacists, pharmacy technicians, pharmacist interns, pharmacies, hospitals, nursing homes, public health clinics, drug research facilities and boarding homes. The Board also educates the public about the proper use of prescription medications.
The Board of Pharmacy investigates complaints dealing with misfilled prescriptions; controlled substance thefts; dispensing adulterated and unapproved drugs; failure to properly communicate side effects of prescription medications to patients; and other violations dealing with unprofessional conduct.
The Board administers and enforces the Pharmacy Act, the Drug Device and Cosmetic Act, the Controlled Substance Act, the Drug Precursor Act, and the Drug Product Selection Act.
IF YOU ARE A MILITARY SERVICE MEMBER, THE SPOUSE OF A MILITARY SERVICE MEMBER, OR A RECENT VETERAN TRANSFERRING YOUR PHARMACIST LICENSE FROM ANOTHER STATE, PLEASE CONTACT ROCIO CRUZ 505-222-9833.
*NOTICE REGARDING CREDIT CARD PAYMENTS*
*As of Friday, December 1, 2017, RLD will no longer accept Credit Card payments in person at RLD offices, nor by electronic mail (email), or direct mail.
*RLD will continue to accept checks and money orders (no cash) at all RLD offices (Santa Fe, Albuquerque and Las Cruces) or by direct mail. However, please do not send Credit Card information to RLD by electronic mail (e-mail) or by direct mail. On and after December 1, 2017, credit card information received via email or regular mail will be destroyed without processing.
*RLD will continue to accept Credit Card payments through our existing secure online systems that can be accessed via the Internet from your home, place of business, or mobile Internet device.
*No credit card breach of data incidents have occurred to date. However, RLD is changing credit card processing to ensure a secure system is maintained in the future.
USP <800> became effective December 1, 2019, and applies to both sterile and non-sterile hazardous drug compounding. A USP <800> Gap Analysis Tool is available at: http://www.800gaptool.com/
SCAM PHONE CALLS TARGETING PHARMACISTS
Volunteers Sought For Continuous Professional Development Project
Monitored Treatment Program reminder
After Hours Diversion Emergencies – 505-469-5641
Licensing, PMP, and Administrative issues – Please call numbers below during business hours
Cheranne McCracken, R.Ph., Executive Director/Chief Drug Inspector
(Questions regarding rules, drug diversion, complaints, inspections, presentation of law updates, web updates, etc)
Kristina Benavidez, Licensing Assistant